Details of the Drug Reposition

General Information of This Drug (ID: DMUQ1DO)

Drug Name
ITI-007   DMUQ1DO
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Schizophrenia DISSRV2N 6A20 Phase 3 [1]
Depression DIS3XJ69 6A70-6A7Z Phase 3 [2]
Insomnia DIS0AFR7 7A00-7A0Z Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02469155) A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)